Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382562 · ClinicalTrials.gov registry record · NA
Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients
A NA study, sponsored by University of Mississippi Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02382562 is a NA study that was terminated before completion, run by University of Mississippi Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT02382562, a NA study, was terminated before completion, sponsored by University of Mississippi Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Depression and other unhealthy behaviors, such as not taking medication as prescribed and not attending doctor visits have been suggested to increase the worsening of allergic diseases (e.g. asthma, urticaria). We intend to determine whether a one-session behavioral intervention is effective in helping with depression and controlling disease symptoms. We will measure this using pre- and post-intervention surveys.
Interventions
- BEHAVIORAL Brief Behavioral Activation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02382562
The ClinicalTrials.gov registry entry for NCT02382562 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief Behavioral Activation Intervention is the first listed.
NCT02382562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02382562 about?
NCT02382562 is a clinical study titled "Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients". Depression and other unhealthy behaviors, such as not taking medication as prescribed and not attending doctor visits have been suggested to increase the worsening of allergic diseases (e.g. asthma, urticaria). We intend to determine whether a one-session behavioral intervention is effective in help...
What is the current status of trial NCT02382562?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2015-05. Estimated completion is 2016-10-17.
What interventions are being tested in trial NCT02382562?
The interventions under investigation include: Brief Behavioral Activation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02382562?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.